NCT00125723View on ClinicalTrials.gov

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

PHASE4CompletedINTERVENTIONAL

Enrollment

2,252

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Neutropenia

Interventions

OTHER

PI Discretion

PI Discretion

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY